Transcobalamin-II variants, decreased vitamin B12 availability and increased risk of frailty

Journal of Nutrition, Health and Aging

Volumn 14, Issue 1, 2010, Pages 73-77

  Matteini, Amy M ^a,d   Walston, J D ^a   Bandeen Roche, K ^a   Arking, D E ^a   Allen, R H ^b   Fried, L P ^c   Chakravarti, A ^a   Stabler, S P ^b   Fallin, M D ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Columbia University Mailman School of Public Health ^*  (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Genetic association; Transcobalamin II; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOLOGICAL MARKER; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HAPTOCORRIN; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLMALONIC ACID; TRANSCOBALAMIN II;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; ENERGY METABOLISM; FEMALE; FOLLOW UP; FRAIL ELDERLY; FRAILTY SYNDROME; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERIATRIC DISORDER; HAPLOTYPE; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METHYLMALONIC ACIDEMIA; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TRANSPORT AND BINDING PHENOMENA; VITAMIN METABOLISM; VITAMIN TRANSPORT;

EID: 76749137605     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-010-0013-1     Document Type: Article

References (37)

1. Buchner, D.M. and E.H. Wagner, Preventing frail health. Clin Geriatr Med, 1992. 8(1): p. 1-17.
2. Fried, L.P., C.M. Tangen, J. Walston, et al., Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001. 56(3): p. M146-56.
3. Fried, L.P. and J. Walston, Frailty and Failure to Thrive, in Principles of Geriatric Medicine and Gerontology, W.R. Hazzard, et al., Editors. 1999, McGraw Hill: New York. p. 1387-1402.
4. Studenski, S., R.P. Hayes, R.Q. Leibowitz, et al., Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment. J Am Geriatr Soc, 2004. 52(9): p. 1560-6.
5. Bandeen-Roche, K., Q.L. Xue, L. Ferrucci, et al., Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci, 2006. 61(3): p. 262-6.
6. Walston, J., E.C. Hadley, L. Ferrucci, et al., Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc, 2006. 54(6): p. 991-1001.
7. Depeint, F., W.R. Bruce, N. Shangari, R. Mehta, and P.J. O'Brien, Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact, 2006. 163(1-2): p. 113-32.
8. Kluijtmans, L.A., I.S. Young, C.A. Boreham, et al., Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood, 2003. 101(7): p. 2483-8.
9. Botto, N., M.G. Andreassi, S. Manfredi, et al., Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet, 2003. 11(9): p. 671-8.
10. Andreassi, M.G., N. Botto, F. Cocci, et al., Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet, 2003. 112(2): p. 171-7.
11. Ma, J., M.J. Stampfer, B. Christensen, et al., A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 1999. 8(9): p. 825-9.
12. Aras, O., N.Q. Hanson, F. Yang, and M.Y. Tsai, Influence of 699C->T and 1080C->T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels. Clin Genet, 2000. 58(6): p. 455-9.
13. Miller, J.W., M.I. Ramos, M.G. Garrod, M.A. Flynn, and R. Green, Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood, 2002. 100(2): p. 718-20.
14. Herrmann, W., R. Obeid, H. Schorr, and J. Geisel, Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med, 2003. 41(11): p. 1478-88.
15. Matteini, A.M., J.D. Walston, M.D. Fallin, et al., Markers of B-vitamin deficiency and frailty in older women. J Nutr Health Aging, 2008. 12(5): p. 303-8.
16. Guralnik, J.M., L.P. Fried, E.M. Simonsick, D. Kasper, and M.E. Lafferty, The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability, in NIH Publication No. 95-4009, N.I.o. Aging., Editor. 1995, National Institute on Aging.: Bethesda, MD.
17. Fried, L.P., K. Bandeen-Roche, P.H. Chaves, and B.A. Johnson, Preclinical mobility disability predicts incident mobility disability in older women. J Gerontol A Biol Sci Med Sci, 2000. 55(1): p. M43-52.
18. Folstein, M.F., S.E. Folstein, and P.R. McHugh, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975. 12(3): p. 189-98.
19. Allen, R.H., S.P. Stabler, D.G. Savage, and J. Lindenbaum, Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism, 1993. 42(8): p. 978-88.
20. Stabler, S.P., R.H. Allen, L.P. Fried, et al., Racial differences in prevalence of cobalamin and folate deficiencies in disabled elderly women. Am J Clin Nutr, 1999. 70(5): p. 911-9.
21. Stabler, S.P., J. Lindenbaum, D.G. Savage, and R.H. Allen, Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood, 1993. 81(12): p. 3404-13.
22. HapMap, I.C., A haplotype map of the human genome. 2005. 437(7063): p. 1299-1320.
23. HapMap, I.C., The International HapMap Project. Nature, 2003. 426(6968): p. 789-96.
24. Oliphant, A., D.L. Barker, J.R. Stuelpnagel, and M.S. Chee, BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques, 2002. Suppl: p. 56-8, 60-1.
25. Gunderson, K.L., S. Kruglyak, M.S. Graige, et al., Decoding randomly ordered DNA arrays. Genome Res, 2004. 14(5): p. 870-7.
26. Stata, C., Intercooled Stata 9.0 for Windows, StataCorp, Editor. 1984, StataCorp LP: College Station, TX.
27. Barrett, J.C., B. Fry, J. Maller, and M.J. Daly, Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 2005. 21(2): p. 263-5.
28. Lake, S.L., H. Lyon, K. Tantisira, et al., Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered, 2003. 55(1): p. 56-65.
29. Schaid, D.J., C.M. Rowland, D.E. Tines, R.M. Jacobson, and G.A. Poland, Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet, 2002. 70(2): p. 425-34.
30. Yates, Z. and M. Lucock, Methionine synthase polymorphism A2756G is associated with susceptibility for thromboembolic events and altered B vitamin/thiol metabolism. Haematologica, 2002. 87(7): p. 751-6; discussion 756.
31. Laraqui, A., A. Allami, A. Carrie, et al., Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Acta Cardiol, 2006. 61(1): p. 51-61.
32. Chandler, R.J., J. Sloan, H. Fu, et al., Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet, 2007. 8: p. 64.
33. Namour, F., J. Olivier, I. Abdelmouttaleb, et al., Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood, 2001. 97(4): p. 1092-8.
34. Li, N., S. Seetharam, J. Lindemans, et al., Isolation and sequence analysis of variant forms of human transcobalamin II. Biochim Biophys Acta, 1993. 1172(1-2): p. 21-30.
35. Afman, L.A., K.J. Lievers, N.M. van der Put, F.J. Trijbels, and H.J. Blom, Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet, 2002. 10(7): p. 433-8.
36. Li, N., G.K. Sood, S. Seetharam, and B. Seetharam, Polymorphism of human transcobalamin II: substitution of proline and/or glutamine residues by arginine. Biochim Biophys Acta, 1994. 1219(2): p. 515-20.
37. Goodman, S.N., Multiple comparisons, explained. Am J Epidemiol, 1998. 147(9): p. 807-12; discussion 815.